HRP20191862T1 - Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina - Google Patents
Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina Download PDFInfo
- Publication number
- HRP20191862T1 HRP20191862T1 HRP20191862TT HRP20191862T HRP20191862T1 HR P20191862 T1 HRP20191862 T1 HR P20191862T1 HR P20191862T T HRP20191862T T HR P20191862TT HR P20191862 T HRP20191862 T HR P20191862T HR P20191862 T1 HRP20191862 T1 HR P20191862T1
- Authority
- HR
- Croatia
- Prior art keywords
- disease
- antibiotics
- fragment
- vitro diagnostic
- caused
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/585—Calcitonins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09157886 | 2009-04-14 | ||
| PCT/EP2010/002279 WO2010118855A1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
| EP10717531.7A EP2419741B1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20191862T1 true HRP20191862T1 (hr) | 2019-12-27 |
Family
ID=40886944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20191862TT HRP20191862T1 (hr) | 2009-04-14 | 2010-04-14 | Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina |
Country Status (15)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014MN02101A (cg-RX-API-DMAC10.html) | 2012-04-12 | 2015-08-28 | Brahms Gmbh | |
| CN105528511A (zh) * | 2014-10-25 | 2016-04-27 | 潘一琦 | 一种远程诊疗对比式问诊方法及其系统 |
| CN107301319B (zh) * | 2017-06-26 | 2021-02-26 | 济南市儿童医院 | 儿科临床及科研中抗菌药物使用危险评估系统 |
| EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
| WO2019122088A1 (en) * | 2017-12-20 | 2019-06-27 | B.R.A.H.M.S Gmbh | Antibiotic therapy guidance based on procalcitonin in patients with comorbidities |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
| DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
| EP1110970B1 (de) * | 1999-12-22 | 2008-05-14 | Dade Behring Marburg GmbH | Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung |
| DE60233949D1 (de) * | 2001-08-20 | 2009-11-19 | Biosite Inc | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon |
| US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| DE102005034174A1 (de) * | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
| FR2894675B1 (fr) * | 2005-12-14 | 2008-06-27 | Assist Publ Hopitaux De Paris | Distinction des meningites bacteriennes et virales |
| DE102006046996A1 (de) | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
| ATE533061T1 (de) | 2007-08-03 | 2011-11-15 | Brahms Gmbh | Verfahren zur diagnose bakterieller infektionen |
-
2010
- 2010-04-14 HU HUE10717531A patent/HUE046182T2/hu unknown
- 2010-04-14 SI SI201031945T patent/SI2419741T1/sl unknown
- 2010-04-14 PL PL10717531T patent/PL2419741T3/pl unknown
- 2010-04-14 LT LT10717531T patent/LT2419741T/lt unknown
- 2010-04-14 DK DK10717531T patent/DK2419741T3/da active
- 2010-04-14 JP JP2012505086A patent/JP5650718B2/ja active Active
- 2010-04-14 EP EP10717531.7A patent/EP2419741B1/en not_active Revoked
- 2010-04-14 WO PCT/EP2010/002279 patent/WO2010118855A1/en not_active Ceased
- 2010-04-14 CN CN201510626744.9A patent/CN105334330A/zh active Pending
- 2010-04-14 PT PT107175317T patent/PT2419741T/pt unknown
- 2010-04-14 US US13/264,252 patent/US9046532B2/en active Active
- 2010-04-14 CN CN201080016849.8A patent/CN102395888B/zh active Active
- 2010-04-14 ES ES10717531T patent/ES2751105T3/es active Active
- 2010-04-14 HR HRP20191862TT patent/HRP20191862T1/hr unknown
-
2015
- 2015-03-30 US US14/672,801 patent/US9810699B2/en active Active
-
2016
- 2016-08-16 HK HK16109795.0A patent/HK1221766A1/zh unknown
-
2017
- 2017-11-06 US US15/804,282 patent/US20180052179A1/en not_active Abandoned
-
2019
- 2019-10-24 CY CY20191101107T patent/CY1122202T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2419741T1 (sl) | 2019-12-31 |
| EP2419741A1 (en) | 2012-02-22 |
| CN102395888A (zh) | 2012-03-28 |
| CN102395888B (zh) | 2017-05-03 |
| EP2419741B1 (en) | 2019-07-31 |
| JP5650718B2 (ja) | 2015-01-07 |
| LT2419741T (lt) | 2019-11-11 |
| DK2419741T3 (da) | 2019-11-04 |
| CY1122202T1 (el) | 2020-11-25 |
| CN105334330A (zh) | 2016-02-17 |
| PL2419741T3 (pl) | 2020-01-31 |
| PT2419741T (pt) | 2019-11-04 |
| ES2751105T3 (es) | 2020-03-30 |
| US20180052179A1 (en) | 2018-02-22 |
| US20150247871A1 (en) | 2015-09-03 |
| US20120100635A1 (en) | 2012-04-26 |
| JP2012523573A (ja) | 2012-10-04 |
| US9810699B2 (en) | 2017-11-07 |
| US9046532B2 (en) | 2015-06-02 |
| WO2010118855A1 (en) | 2010-10-21 |
| HUE046182T2 (hu) | 2020-02-28 |
| HK1221766A1 (zh) | 2017-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190224135A1 (en) | Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease | |
| CN104755930B (zh) | 用于检测分析物的装置和方法 | |
| CN101568833B (zh) | 使用MR-proADM的糖尿病诊断和风险分级 | |
| ES2944613T3 (es) | proADM y/o histonas como marcadores indicadores de un acontecimiento adverso | |
| JP2013545087A5 (cg-RX-API-DMAC10.html) | ||
| JP2025019061A (ja) | 術後有害事象の診断または予後 | |
| JP7277465B2 (ja) | プロカルシトニンと中間領域プロアドレノメデュリンを使用したリスク評価と患者管理のためのワークフロー | |
| EP3497450B1 (en) | Histones and/or proadm as markers indicating organ dysfunction | |
| WO2013090811A1 (en) | Biomarkers of pulmonary hypertension | |
| JP2023041741A (ja) | 重篤患者用の療法モニタリングマーカーとしてのｐｒｏ－ａｄｍ | |
| JP2023095851A (ja) | 抗生物質治療をモニタリングするためのマーカーとしてのｐｃｔおよびｐｒｏ－ａｄｍ | |
| FI3356826T3 (fi) | Gdf-15 melanooman diagnostisena markkerina | |
| JP7402858B2 (ja) | 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ | |
| Chaudhury et al. | Procalcitonin in sepsis and bacterial infections | |
| JP2012523573A5 (cg-RX-API-DMAC10.html) | ||
| Vaziri et al. | Effects of end‐stage renal disease and dialysis modalities on blood ammonia level | |
| RU2009146803A (ru) | Способ диагностики деструктивного панкреатита | |
| Hu et al. | Prognostic value of adrenomedullin and natriuretic peptides in uroseptic patients induced by ureteroscopy | |
| WO2014108397A4 (en) | A method for predicting the risk of getting cancer or diagnosing cancer in a subject | |
| RU2788885C2 (ru) | Прокальцитонин и про-адм в качестве маркеров для мониторинга лечения антибиотиками | |
| US20230093131A1 (en) | Assessing and treating alcohol-associated liver disease | |
| WO2025133235A1 (en) | Adm-gly as marker for early predicting sepsis | |
| WO2021133937A1 (en) | Circulating nedd9 is increased in pulmonary arterial hypertension | |
| Mohammed et al. | Obestatin/Ghrelin Ratio as a New Activity Index in Ulcerative Colitis | |
| RU2014119323A (ru) | Способ прогнозирования риска развития фибрилляции предсердий у пациентов с сердечно-сосудистой патологией |